Kelly M. McMasters is an American surgeon and researcher. He is the Ben A. Reid Sr., MD Professor and Chair of the Hiram C. Polk Jr., MD Department of Surgery at the University of Louisville School of Medicine.
Kelly M. McMasters | |
|---|---|
 | |
| Born | Camden, New Jersey, US |
| Academic background | |
| Education | B.A., Biology, 1983, Colgate University Ph.D., Cell and Developmental Biology, 1988, Rutgers University MD, 1989, Robert Wood Johnson Medical School |
| Thesis | Regulation of gene expression in ovarian granulosa cells (1988) |
| Academic work | |
| Institutions | University of Louisville School of Medicine |
Early life and education
editMcMasters is a native of Camden, New Jersey, US.[1] Following high school, he earned his undergraduate degree in biology from Colgate University and completed the MD/PhD program at Robert Wood Johnson Medical School and Rutgers University. He then completed a General Surgery residency at the University of Louisville School of Medicine (U of L) and Surgical Oncology Fellowship at MD Anderson Cancer Center.[2]
Career
editUpon completing his residency and fellowship, McMasters joined the faculty at U of L as an assistant professor of Surgical Oncology in July 1996.[3] He was shortly thereafter promoted to the Lolita and Sam Weakley Professor of Surgical Oncology where he focused on developing a new treatment for melanoma.[4] His study on this subject enrolled over 830 melanoma patients and coordinated with nearly 80 centers around the United States. By 1999, he was recognized as one of Kentucky's young leaders for the 21st century.[5] At the turn of the century, McMaster's National Sunbelt Melanoma Trial, which had enrolled 1,500 melanoma patients from 60 cancer centers nationwide, became the largest study of melanoma ever conducted.[6] In 2005, McMasters was appointed Chairman of the Department of Surgery at the U of L School of Medicine.[3] While serving in this role, McMasters was appointed to serve on the Scientific Advisory Board for Provectus Pharmaceuticals, Inc.[7]
In October 2017, McMasters was appointed the editor-in-chief of the journal Annals of Surgical Oncology starting in March 2018.[8] A few years later, he was also selected to serve on the executive board for the American Board of Surgery.[1]
Personal life
editMcMasters and his wife Beth have sons together.[9]
References
edit- ^ a b "ABS to Welcome 8 New Directors". The American Board of Surgery. March 13, 2019. Retrieved December 12, 2021.
- ^ "Kelly M. McMasters, M.D., Ph.D." University of Louisville. Retrieved December 12, 2021.
- ^ a b "Kelly M. McMasters, M.D., Ph.D." Rutgers University. 2006. Retrieved December 13, 2021.
- ^ "New Melanoma Treatment Is Being Studied at U of L". The Dawson Springs Progress. April 3, 1997. Retrieved December 13, 2021 – via newspapers.com.
- ^ "Kentucky Young Leaders for the 21st century". The Courier-Journal. September 19, 1999. Retrieved December 13, 2021 – via newspapers.com.
- ^ Moore, Brian (May 26, 2000). "Melanoma clinic streamlines care for skin-cancer patients". The Courier-Journal. Retrieved December 13, 2021 – via newspapers.com.
- ^ "Provectus Pharmaceuticals appoints Kelly M. McMasters, MD, PhD, to board of directors". Provectus Pharmaceuticals, Inc. June 3, 2008. Retrieved December 13, 2021.
- ^ "The Society of Surgical Oncology Announces New Editor-in-Chief for Annals of Surgical Oncology" (Press release). Global Newswire. October 30, 2017. Retrieved December 13, 2021.
- ^ McMasters, Kelly M. (December 4, 2017). "Life, Surgery, and the Philosophy of Dry Creek". Journal of the American Chemical Society. 227 (1): 1–5. doi:10.1016/j.jamcollsurg.2017.11.017. PMID 29217408. S2CID 205681811. Retrieved December 12, 2021.